Articles Vol. 66 No. VoL 66. English Version No 1, 2025 15/08/2025

32. EFFICACY OF THE “DƯỠNG NHAN” HERBAL FACIAL MASK IN TREATING MELASMA IN WOMEN AT THE DERMATOLOGY DEPARTMENT – TUE TINH HOSPITAL, 2024

Nguyen Thi Phuong1
1 Vietnam University of Traditional Medicine
Corresponding author: phuong.nguyen0901@gmail.com
DOI: 10.52163/yhc.v66ienglish.2778
21 Views
85 Downloads
Keywords
treatment outcome melasma Tue Tinh Hospital
Abstract

Objective: To evaluate the efficacy of the “Dưỡng Nhan” herbal facial mask in treating melasma in women at the Dermatology Department – Tue Tinh Hospital in 2024.

Subjects and Methods: This was a clinical interventional study conducted on 30 female patients with melasma at Tue Tinh Hospital from March to August 2024. The therapeutic outcomes of the “Dưỡng Nhan” herbal mask were evaluated based on clinical and paraclinical indicators, as well as assessments of adverse effects.

Results: After 12 weeks of treatment, the mean MASI score significantly decreased from 6.68 to 3.25, with a statistically significant difference (p < 0.001), while the L* value (indicating skin brightness) showed a marked increase. Clinically, 86.6% of patients showed good to excellent improvement. The rate of adverse reactions was very low, with only one case (3.3%) experiencing mild irritation, which resolved completely. Notably, 90% of the patients reported satisfaction and felt confident during the treatment process.

Conclusion: The “Dưỡng Nhan” herbal facial mask is a safe and effective therapy for improving skin pigmentation in melasma after 12 weeks of use. This herbal formulation presents high potential for clinical application and offers a new direction in the development of traditional medicine-based skincare products.

References
[1]
Mpofana Nomakhosi, Chibi Buyisile, Gqaleni Nceba, et al. (2023). Melasma in people with darker skin types: a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life. Systematic Reviews, 12(1): 139. Google Scholar
[2]
Yang Siyu, Zhou Jin (2023). Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome presenting mainly with alveolar hemorrhage: a case report and literature review. Medicine, 102(48): e36356. Google Scholar
[3]
Jin Ya-Bei, Zheng Li-Fang, Sun Zhan-Ling (2019). Effect on clinical symptoms and mechanism of chloasma in premenopausal women with liver qi stagnation treated with acupoint catgut embedding. Zhongguo Zhen jiu Chinese Acupuncture Moxibustion, 39(9): 932-935. Google Scholar
[4]
Pandya A, Berneburg M, Ortonne J‐P, et al. (2006). Guidelines for clinical trials in melasma. British Journal of Dermatology, 156(s1): 21-28. Google Scholar
[5]
Molinar Vanessa E, Taylor Susan C, Pandya Amit G (2014). What’s new in the objective assessment and treatment of facial hyperpigmentation? Dermatologic clinics, 32(2): 123-135. Google Scholar
[6]
Lee S‐J, Son YH, Lee KB, et al. (2017). 4‐n‐butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells. International Journal of Cosmetic Science, 39(3): 248-255. Google Scholar
[7]
Nguyen Tien Thanh & Nguyen Van Thuong (2019). Evaluation of quality-of-life improvement in melasma treatment using QS YAG laser combined with a dual-component product containing 4-N-Butylresorcinol and Tranexamic acid. Journal of Community Medicine, 5(52), 26–32. Google Scholar
[8]
Le Thai Van Thanh (2015). Study on melasma in pregnant women and some intervention measures. Doctoral dissertation in medicine, Hanoi Medical University. Google Scholar
[9]
Nguyen Van Thuong (2005). Study on the prevalence of melasma in non-pregnant women and the outcomes of topical treatment using hydroquinone, retinoic acid, and sunscreen. Doctoral dissertation in medicine, Hanoi Medical University. Google Scholar